Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Seagen Inc.
Mayo Clinic
Kivu Bioscience Inc.
AstraZeneca
STORM Therapeutics LTD
Eli Lilly and Company
Neonc Technologies, Inc.
EMD Serono
Arcus Biosciences, Inc.
Terremoto Biosciences Inc.
Bristol-Myers Squibb
Seagen Inc.
Pfizer
Radiopharm Theranostics, Ltd